Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
1.290
-0.010 (-0.77%)
Apr 1, 2025, 10:03 AM EDT - Market open
Envoy Medical Stock Forecast
COCH's stock price has decreased by -66.84% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Envoy Medical stock have an average target of 8.00, with a low estimate of 6.00 and a high estimate of 9.00. The average target predicts an increase of 520.16% from the current stock price of 1.29.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 6, 2024.
Analyst Ratings
The average analyst rating for Envoy Medical stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.75 → $9 | Strong Buy | Maintains | $8.75 → $9 | +597.67% | Dec 6, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +597.67% | Oct 14, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.5 → $8.75 | Strong Buy | Maintains | $8.5 → $8.75 | +578.29% | Sep 3, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +558.91% | Jun 24, 2024 |
| Lake Street | Lake Street | Strong Buy Maintains $3 → $6 | Strong Buy | Maintains | $3 → $6 | +365.12% | Apr 3, 2024 |
Financial Forecast
Revenue This Year
340.00K
from 225.00K
Increased by 51.11%
Revenue Next Year
652.80K
from 340.00K
Increased by 92.00%
EPS This Year
-1.24
from -1.49
EPS Next Year
-0.57
from -1.24
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 420,000 | 672,000 |
| Avg | 339,997 | 652,800 |
| Low | 294,000 | 627,200 |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 86.7% | 97.6% |
| Avg | 51.1% | 92.0% |
| Low | 30.7% | 84.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -1.21 | -0.59 |
| Avg | -1.24 | -0.57 |
| Low | -1.32 | -0.55 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.